Pepcid

From Practice Parameters
Revision as of 11:37, 12 November 2020 by Mfrdmanager (talk | contribs) (Created page with "==Section 8 - MEDICATION GUIDELINES== ===ANTIHISTAMINES=== ====Famotidine (PEPCID) / H2 Histamine blocker==== '''DESCRIPTION''' * Famotidine inhibits histamine at H2 receptor...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Section 8 - MEDICATION GUIDELINES

ANTIHISTAMINES

Famotidine (PEPCID) / H2 Histamine blocker

DESCRIPTION

  • Famotidine inhibits histamine at H2 receptor site in the gastric parietal cell, which inhibits gastric acid secretion.

INDICATIONS

  • Hives; Allergic reaction; Short term treatment of duodenal and gastric ulcers, management of GERD and erosive esophagitis.

CONTRAINDICATIONS

  • Hypersensitivity to the medication
  • Renal impairment

PRECAUTIONS

  • Hepatic disease, renal disease, elderly

DOSAGE

  • Currently supplied in 20mg/50 ml
  • Adults: 20mg/ 50ml given at a wide open rate.
  • Pediatrics- refer to the Handtevy System.
Retrieved from "http://mfrdinfo.com/ems1/index.php?title=Pepcid&oldid=27680"